We are live on ! Find out more
AFM

Anson Funds Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 370.24%
This Fund
S&P 500
This Quarter Est. Return
-1.54%
1 Year Est. Return
+370.24%
3 Year Est. Return
+1,243.07%
5 Year Est. Return
+867.54%
10 Year Est. Return
+12,575.88%
AUM
$1.02B
AUM Growth
-$36.2M
Cap. Flow
-$10.4M
Cap. Flow %
-1.02%
Top 10 Hldgs %
30.52%
Holding
491
New
188
Increased
28
Reduced
45
Closed
152

Sector Composition

Rank Sector Weight
1 Financials 38.91%
2 Healthcare 5.15%
3 Real Estate 4.9%
4 Consumer Discretionary 4.78%
5 Communication Services 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOGN
301
DELISTED
GoGreen Investments Corporation
GOGN
$209K 0.02%
+21,092
New +$209K
USAS
302
Americas Gold and Silver
USAS
$1.31B
$202K 0.02%
100,000
WPRT
303
Westport Fuel Systems
WPRT
$32.9M
$201K 0.02%
+8,456
New +$242K
GLBS icon
304
Globus Maritime Ltd
GLBS
$60.9M
$191K 0.02%
+90,729
New +$242K
BHAT
305
DELISTED
Blue Hat Interactive Entertainment Technology
BHAT
$187K 0.02%
+9
New +$253K
VMD icon
306
Viemed Healthcare
VMD
$457M
$185K 0.02%
+35,410
New +$198K
WKEY
307
WISeKey
WKEY
$70.4M
$185K 0.02%
+44,492
New +$1.18M
NETI
308
DELISTED
Eneti Inc.
NETI
$182K 0.02%
+23,574
New +$268K
SEED icon
309
Origin Agritech
SEED
$11.9M
$179K 0.02%
+25,000
New +$222K
OVID icon
310
Ovid Therapeutics
OVID
$440M
$176K 0.02%
+54,823
New +$188K
HCVIW
311
DELISTED
Hennessy Capital Investment Corp. VI Warrant
HCVIW
$169K 0.02%
+17,483
New +$14.8K
PNTM.WS
312
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
$163K 0.02%
16,666
IMPL
313
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$153K 0.02%
+17,729
New +$177K
IMMR icon
314
Immersion
IMMR
$254M
$150K 0.01%
+26,218
New +$173K
SHPW
315
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
$150K 0.01%
+5,067
New +$238K
DLPN icon
316
Dolphin Entertainment
DLPN
$13.8M
$147K 0.01%
+8,605
New +$176K
ALTU
317
DELISTED
Altitude Acquisition Corp
ALTU
$145K 0.01%
14,600
ORIAW
318
DELISTED
Orion Biotech Opportunities Corp. Warrant
ORIAW
$145K 0.01%
15,000
ADVM
319
DELISTED
Adverum Biotechnologies
ADVM
$144K 0.01%
+8,182
New +$164K
LSTA icon
320
Lisata Therapeutics
LSTA
$10.6M
$143K 0.01%
+11,295
New +$174K
HCCC
321
DELISTED
Healthcare Capital Corp. Class A common stock
HCCC
$141K 0.01%
14,328
-200,000
-93% -$1.98M
BBLN.WS
322
DELISTED
Babylon Holdings Limited Warrants, each exercisable for one Class A Ordinary Share
BBLN.WS
$136K 0.01%
+23,329
New +$27.8K
APT icon
323
Alpha Pro Tech
APT
$51.1M
$133K 0.01%
+22,310
New +$130K
GTBP icon
324
GT Biopharma
GTBP
$11.4M
$133K 0.01%
+1,456
New +$218K
OABIW icon
325
OmniAb Inc Warrant
OABIW
$10.2M
$133K 0.01%
+13,333
New +$8.34K

Similar funds

Anson Funds Management's Q4 2021 Portfolio in Review

As of Q4 2021, Anson Funds Management held 491 positions worth $1.02B, down 3.4% from $1.06B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Anson Funds Management's Q4 2021 filing shows 188 new, 28 increased, 45 reduced and 152 closed positions. Its largest new stake was Allakos: 454,496 shares worth $4.45M. The largest sale was Hovnanian Enterprises, an estimated $16.7M.

By sector, the portfolio is most concentrated in Financials at 39% of assets, down from 40% a quarter earlier, followed by Healthcare and Real Estate.

  • Anson Funds Management's largest Q4 2021 buy was Allakos: 454,496 shares worth $4.45M.
  • Anson Funds Management added most to Compass Pathways in Q4 2021, an estimated $14.9M increase.
  • Anson Funds Management's biggest Q4 2021 reduction was Hovnanian Enterprises, cutting an estimated $16.7M.
  • Anson Funds Management fully exited Aurora in Q4 2021, selling an estimated $16.4M.
  • Anson Funds Management's ten largest holdings make up 31% of its $1.02B portfolio in Q4 2021.
  • Anson Funds Management opened 188 new positions and closed 152 in Q4 2021.
  • Anson Funds Management's portfolio value fell 3.4% quarter-over-quarter to $1.02B.

Based on Anson Funds Management's 13F filing for Q4 2021, filed 14 Feb 2022.